SunTrust Banks Lowers UnitedHealth Group (UNH) Price Target to $300.00

UnitedHealth Group (NYSE:UNH) had its price target cut by equities researchers at SunTrust Banks to $300.00 in a research note issued to investors on Wednesday, The Fly reports. The brokerage presently has a “buy” rating on the healthcare conglomerate’s stock. SunTrust Banks’ target price would suggest a potential upside of 35.77% from the company’s previous close. The analysts noted that the move was a valuation call.

UNH has been the subject of a number of other research reports. Stephens began coverage on UnitedHealth Group in a research note on Monday, January 14th. They issued an “overweight” rating and a $287.00 price objective for the company. ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, February 27th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $279.00 price objective for the company in a research note on Saturday, January 5th. Cantor Fitzgerald reiterated a “buy” rating and issued a $310.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, January 15th. Finally, Credit Suisse Group reiterated a “buy” rating and issued a $310.00 price objective on shares of UnitedHealth Group in a research note on Friday, February 8th. Three investment analysts have rated the stock with a hold rating and twenty have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $297.80.

UNH stock opened at $220.96 on Wednesday. The company has a market cap of $220.89 billion, a P/E ratio of 17.16, a price-to-earnings-growth ratio of 1.18 and a beta of 0.79. UnitedHealth Group has a fifty-two week low of $215.82 and a fifty-two week high of $287.94. The company has a debt-to-equity ratio of 0.64, a current ratio of 0.73 and a quick ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.60 by $0.13. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. The company had revenue of $60.30 billion during the quarter, compared to analysts’ expectations of $59.72 billion. During the same quarter in the previous year, the business earned $3.04 earnings per share. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. As a group, sell-side analysts anticipate that UnitedHealth Group will post 14.63 earnings per share for the current fiscal year.

In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction on Tuesday, January 22nd. The stock was sold at an average price of $266.61, for a total value of $1,333,050.00. Following the completion of the sale, the director now owns 77,702 shares of the company’s stock, valued at $20,716,130.22. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Gail R. Wilensky sold 2,930 shares of the firm’s stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $253.39, for a total value of $742,432.70. Following the completion of the sale, the director now directly owns 64,726 shares of the company’s stock, valued at approximately $16,400,921.14. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 32,930 shares of company stock valued at $8,495,383. Corporate insiders own 0.87% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in the business. Crewe Advisors LLC purchased a new stake in UnitedHealth Group in the 4th quarter valued at about $25,000. Pearl River Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $35,000. Canton Hathaway LLC bought a new stake in shares of UnitedHealth Group in the 1st quarter valued at approximately $36,000. Ipswich Investment Management Co. Inc. bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $40,000. Finally, OLD Second National Bank of Aurora increased its holdings in shares of UnitedHealth Group by 70.0% in the 4th quarter. OLD Second National Bank of Aurora now owns 170 shares of the healthcare conglomerate’s stock valued at $42,000 after acquiring an additional 70 shares during the last quarter. 86.68% of the stock is owned by institutional investors.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Story: What is a Leveraged Buyout (LBO)?

The Fly

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.